» Articles » PMID: 10390238

Characterization of New Mutations in Pyrazinamide-resistant Strains of Mycobacterium Tuberculosis and Identification of Conserved Regions Important for the Catalytic Activity of the Pyrazinamidase PncA

Overview
Specialty Pharmacology
Date 1999 Jul 2
PMID 10390238
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

A new set of mutations, including transposition of the insertion sequence IS6110, was identified in the pncA gene from 19 pyrazinamide-resistant Mycobacterium tuberculosis strains. Alignment of the PncA protein from M. tuberculosis with homologous proteins from different bacterial species revealed three highly conserved regions in PncA which may play an important role in the processing of pyrazinamide.

Citing Articles

Studying the dynamics of the drug processing of pyrazinamide in Mycobacterium tuberculosis.

Requena D, Supo-Escalante R, Sheen P, Zimic M PLoS One. 2024; 19(8):e0309352.

PMID: 39208342 PMC: 11361689. DOI: 10.1371/journal.pone.0309352.


Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India.

Suresh P, Thulasidharan S, Kumar A, Sunil S, Roy M, Ramesh V Am J Trop Med Hyg. 2024; 111(1):161-167.

PMID: 38772358 PMC: 11229631. DOI: 10.4269/ajtmh.24-0042.


Mycobacterium Time-Series Genome Analysis Identifies AAC2' as a Potential Drug Target with Naloxone Showing Potential Bait Drug Synergism.

Niranjan V, Uttarkar A, Murali K, Niranjan S, Gopal J, Kumar J Molecules. 2022; 27(19).

PMID: 36234683 PMC: 9571707. DOI: 10.3390/molecules27196150.


Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update.

Rajendran A, Palaniyandi K Curr Microbiol. 2022; 79(11):348.

PMID: 36209317 DOI: 10.1007/s00284-022-03032-y.


Detection of Mutations in in Clinical Isolates from Nepal in Association with Pyrazinamide Resistance.

Shrestha D, Maharjan B, Thapa J, Akapelwa M, Bwalya P, Chizimu J Curr Issues Mol Biol. 2022; 44(9):4132-4141.

PMID: 36135195 PMC: 9497661. DOI: 10.3390/cimb44090283.


References
1.
Fang Z, Forbes K . A Mycobacterium tuberculosis IS6110 preferential locus (ipl) for insertion into the genome. J Clin Microbiol. 1997; 35(2):479-81. PMC: 229605. DOI: 10.1128/jcm.35.2.479-481.1997. View

2.
Scorpio A, Heifets L, Gilman R, Siddiqi S, Cynamon M, Zhang Y . Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1997; 41(3):540-3. PMC: 163747. DOI: 10.1128/AAC.41.3.540. View

3.
Sreevatsan S, Pan X, Zhang Y, Kreiswirth B, Musser J . Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother. 1997; 41(3):636-40. PMC: 163764. DOI: 10.1128/AAC.41.3.636. View

4.
Fomukong N, Beggs M, Hajj H, Templeton G, Eisenach K, Cave M . Differences in the prevalence of IS6110 insertion sites in Mycobacterium tuberculosis strains: low and high copy number of IS6110. Tuber Lung Dis. 1997; 78(2):109-16. DOI: 10.1016/s0962-8479(98)80003-8. View

5.
Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C . Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuber Lung Dis. 1997; 78(2):117-22. DOI: 10.1016/s0962-8479(98)80004-x. View